William P. Sheffield

2.5k total citations
125 papers, 2.0k citations indexed

About

William P. Sheffield is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, William P. Sheffield has authored 125 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Hematology, 46 papers in Molecular Biology and 31 papers in Cancer Research. Recurrent topics in William P. Sheffield's work include Blood Coagulation and Thrombosis Mechanisms (47 papers), Protease and Inhibitor Mechanisms (31 papers) and Blood transfusion and management (22 papers). William P. Sheffield is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (47 papers), Protease and Inhibitor Mechanisms (31 papers) and Blood transfusion and management (22 papers). William P. Sheffield collaborates with scholars based in Canada, United States and United Kingdom. William P. Sheffield's co-authors include Varsha Bhakta, Louise J. Eltringham‐Smith, G C Shore, Stephen K. Randall, Morris A. Blajchman, MA Blajchman, Craig Jenkins, F Fernandez-Rachubinski, Syed M. Qadri and Dana V. Devine and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

William P. Sheffield

121 papers receiving 2.0k citations

Peers

Countries citing papers authored by William P. Sheffield

Since Specialization

Citations

This map shows the geographic impact of William P. Sheffield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William P. Sheffield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William P. Sheffield more than expected).

Fields of papers citing papers by William P. Sheffield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William P. Sheffield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William P. Sheffield. The network helps show where William P. Sheffield may publish in the future.

Co-authorship network of co-authors of William P. Sheffield

This figure shows the co-authorship network connecting the top 25 collaborators of William P. Sheffield. A scholar is included among the top collaborators of William P. Sheffield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William P. Sheffield. William P. Sheffield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Substitution of reactive centre loop residues from C1 esterase inhibitor increases the inhibitory specificity of alpha-1 antitrypsin for plasma kallikrein 2025 ·Journal of Biotechnology ·(unknown), Salman Ahmed, (unknown), Varsha Bhakta, William P. Sheffield	0
2	Extension of the circulatory half-life of recombinant ecallantide via albumin fusion without loss of anti-kallikrein activity 2024 ·Journal of Biotechnology ·(unknown), Varsha Bhakta, Louise J. Eltringham‐Smith, (unknown), William P. Sheffield	1
3	Correction of haemorrhagic shock-associated coagulopathy and impaired haemostasis by plasma, prothrombin complex concentrates or an activated protein C-targeted DNA aptamer in mice 2023 ·Scientific Reports ·Louise J. Eltringham‐Smith, Scott C. Meixner, Edward L.G. Pryzdial, William P. Sheffield	1
4	Elaborative Simplification as Implicit Questions Under Discussion 2023 ·Yating Wu, William P. Sheffield, Kyle Mahowald, Junyi Li	3
5	The bending rigidity of the red blood cell cytoplasmic membrane 2022 ·PLoS ONE ·Sebastian Himbert, Angelo D’Alessandro, Syed M. Qadri, (unknown), Todd Hoare, William P. Sheffield, Michihiro Nagao, John F. Nagle, Maikel C. Rheinstädter	25
6	Inductively-Coupled Plasma Mass Spectrometry–Novel Insights From an Old Technology Into Stressed Red Blood Cell Physiology 2022 ·Frontiers in Physiology ·Daniel Stephenson, Travis Nemkov, Syed M. Qadri, William P. Sheffield, Angelo D’Alessandro	9
7	Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin 2021 ·Journal of Biotechnology ·Louise J. Eltringham‐Smith, Varsha Bhakta, William P. Sheffield	4
8	Thrombospondin-1/CD47 signaling modulates transmembrane cation conductance, survival, and deformability of human red blood cells 2020 ·Cell Communication and Signaling ·Rosi Bissinger, Polina Petkova‐Kirova, (unknown), Per‐Arne Oldenborg, (unknown), (unknown), Thomas H. Dietz, Abdulla Al Mamun Bhuyan, William P. Sheffield, Marijke Grau, Ferruh Artunç, Lars Kaestner, Jason P. Acker, Syed M. Qadri	13
9	Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy 2019 ·Scientific Reports ·Louise J. Eltringham‐Smith, Ruoying Yu, Syed M. Qadri, Yiming Wang, Varsha Bhakta, Edward L.G. Pryzdial, Jeffrey R. Crosby, Heyu Ni, William P. Sheffield	2
10	CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fcγ Receptor– and Complement Receptor 3–Dependent Mechanisms 2016 ·The Journal of Immunology ·Alaa Amash, Lin Wang, Yawen Wang, Varsha Bhakta, Gregory D. Fairn, Ming Hou, Jun Peng, William P. Sheffield, Alan H. Lazarus	22
11	Quality Assessment of Established and Emerging Blood Components for Transfusion 2016 ·SHILAP Revista de lepidopterología ·Jason P. Acker, Denese C. Marks, William P. Sheffield	51
12	γT‐S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo 2014 ·Journal of Thrombosis and Haemostasis ·William P. Sheffield, (unknown), Louise J. Eltringham‐Smith, Varsha Bhakta, Donald M. Arnold, Mark Crowther	10
13	The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand 2013 ·BMC Biochemistry ·Amanda J. Boyle, (unknown), Varsha Bhakta, (unknown), M.S. Junop, Patricia C. Liaw, Jeffrey I. Weitz, William P. Sheffield	6
14	In VivoClearance of Alpha-1 Acid Glycoprotein Is Influenced by the Extent of Its N-Linked Glycosylation and by Its Interaction with the Vessel Wall 2012 ·SHILAP Revista de lepidopterología ·(unknown), Varsha Bhakta, Louise J. Eltringham‐Smith, (unknown), Alison Fox‐Robichaud, William P. Sheffield	11
15	Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris 2012 ·Regulatory Peptides ·Mercedes L. Kuroski de Bold, William P. Sheffield, (unknown), Varsha Bhakta, Louise J. Eltringham‐Smith, Joseph F. DeBold	21
16	Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa 2011 ·BMC Biotechnology ·William P. Sheffield, Louise J. Eltringham‐Smith	6
17	Detection of antibodies reacting with the antithetical duffy blood group antigens Fya and Fyb using recombinant fusion proteins containing the duffy extracellular domain 2006 ·Transfusion and Apheresis Science ·William P. Sheffield, Varsha Bhakta, Donald R. Branch, Gregory A. Denomme	4
18	Blood Group Biochemistry: A Canadian Blood Services Research and Development Symposium 2005 ·Transfusion Medicine Reviews ·William P. Sheffield, Alan Tinmouth, Donald R. Branch	10
19	Heparin cofactor II is more sensitive than antithrombin to secretory impairment arising from mutations introduced into its carboxy-terminal region 2004 ·Thrombosis Research ·Varsha Bhakta, Megan E. Begbie, (unknown), Vicky Sandhu, William P. Sheffield	5
20	Prolonged in vivo anticoagulant activity of a hirudin–albumin fusion protein secreted from Pichia pastoris 2001 ·Blood Coagulation & Fibrinolysis ·William P. Sheffield, Ian Smith, Shorabuddin Syed, Varsha Bhakta	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact